Cxcr1 and cxcr2 chemokine antagonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 333/36 (2006.01) A61K 31/341 (2006.01) A61K 31/381 (2006.01) A61K 31/4025 (2006.01) A61K 31/4152 (2006.01) A61K 31/4155 (2006.01) A61K 31/425 (2006.01) A61K 31/427 (2006.01) A61K 31/4436 (2006.01) C07D 207/34 (2006.01) C07D 231/38 (2006.01) C07D 275/02 (2006.01) C07D 409/04 (2006.01) C07D 409/12 (2006.01) C07D 417/12 (2006.01)

Patent

CA 2565519

The present invention is directed to a compound having the general structure of formula (1) useful for the treatment, prevention or amelioration of a CXCR1 or CXCR2 chemokine-mediated disease.

La présente invention concerne un composé dont la structure générale est représentée par la formule (1). Ce composé est utile pour le traitement, la prévention ou l'atténuation d'une maladie médiée par la chimiokine CXCR1 ou CXCR2.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Cxcr1 and cxcr2 chemokine antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cxcr1 and cxcr2 chemokine antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cxcr1 and cxcr2 chemokine antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1867556

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.